Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Open-label, Randomized, Single Dose, Two-way Crossover Design to Evaluate theBioequivalence of Two Different Pimicotinib Capsules Under Fasting Conditions in Healthy Subjects

NCT07126249 is registered in ClinicalTrials.gov with Abbisko Therapeutics Co, Ltd as lead sponsor.

NCT NCT07126249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07126249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Open-label, Randomized, Single Dose, Two-way Crossover Design to Evaluate theBioequivalence of Two Different Pimicotinib Capsules Under Fasting Conditions in Healthy Subjects
Lead sponsor
Abbisko Therapeutics Co, Ltd
Phase
Phase 1
Overall status
Completed
Start date
May 13, 2025
Completion date
June 16, 2025
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics